SCHEMBL17850512

SCHEMBL17850512

Cc1ncncc1S(=O)(=O)Cl

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 5/20 0.33
CDC25B P30305 1/20 0.33
ACLY P53396 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8148245 0.81 CYP17A1 (0.37) CYP17A1CDC25B
SCHEMBL24783468 0.76 CYP17A1 (0.33) CYP17A1
SCHEMBL3018205 0.71 KMT2A (0.39)
SCHEMBL25226442 0.71 APLNR (0.35)
SCHEMBL21046903 0.69 TRPV4 (0.38)
SCHEMBL29837763 0.68 TRPV4 (0.44)
SCHEMBL26694042 0.68 TRPV4 (0.44)
SCHEMBL1827106 0.68 TRPV4 (0.51)
SCHEMBL29673491 0.68 TRPV4 (0.51)
SCHEMBL28574238 0.68 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643299-B1 BIPYRIDINE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES OR CONDITIONS NOSCIRA SA (ES) 2016-06-22 EP disclosed